This review outlines the data supporting various antiplatelet and anticoagulant therapies and their combinations in patients with acute coronary syndromes.
This review summarizes the evidence supporting various antiplatelet and anticoagulant therapies in the acute and chronic management of acute coronary syndromes.
The past 2 decades have witnessed the introduction and demise of several different antithrombotic medications for acute coronary syndromes. Part of the assessment of these compounds has been their effect on thrombotic events relative to the degree of increase in bleeding events. This review will outline the data supporting various antiplatelet and anticoagulant therapies and their combinations in patients with acute coronary syndromes and related disorders in both the acute and chronic phases of therapy.
Bhatt et al. (2014) conducted a review in Acute coronary syndromes. Antiplatelet and anticoagulant therapies was evaluated. This review outlines the data supporting various antiplatelet and anticoagulant therapies and their combinations in patients with acute coronary syndromes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: